Rebecca Jane Cox

Leder av Influensasenteret /Professor

University of Bergen

Norway

Research Interests

Explore related searches

Professors in Norway Professors in Immunology Immunology professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rebecca Jane Cox is a Professor at Universitet i Bergen, Norway. Her research primarily focuses on influenza immunology, vaccine development, and the antibody responses to viral infections, as highlighted in her recent articles. She has contributed to studies on the effects of pre-existing immunity on vaccine responses, vaccine trial participation challenges, and the detection of SARS-CoV-2 antibodies among health care workers.

Articles (11)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (7)

Petr Husa

Head

Masarykova Univerzita Filozofická Fakulta

CZECH REPUBLIC

View details

Anna Maria AZZINI

Aggregate Professor

University of Verona

ITALY

View details

Nina Langeland

Professor

University of Bergen

NORWAY

View details

Karl Albert Brokstad

Professor

Western Norway University of Applied Sciences

NORWAY

View details

Bjorn Blomberg

Associate professor

University of Bergen

NORWAY

View details

Christoph Merten

Professor

EPFL Institute of Bioengineering

SWITZERLAND

View details

Ole Olesen

Københavns Universitet

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rebecca Jane Cox

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Impact of Pre-Existing Immunity and Age on Antibody Responses to Live Attenuated Influenza Vaccine

Unravelling influenza correlates of protection: lessons from human A/H1N1 Challenge

Targeted barcoding of variable antibody domains and individual transcriptomes of the human B-cell repertoire using Link-Seq

Meeting Report From “Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID‐19 Pandemic”

The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium

Lower antibiotic prescription rates in hospitalized COVID-19 patients than influenza patients, a prospective study

The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection

SARS CoV-2 Infection among Health Care Workers from Different Health Care Facilities in Western Norway: A Prospective, Cross-Sectional Study

Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A/H3N2 viruses

Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response

Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines

Collaborators (7)

Petr Husa

Anna Maria AZZINI

Nina Langeland

Karl Albert Brokstad

Bjorn Blomberg

Christoph Merten

Ole Olesen

Make your next move.